March 2021 – DRUG DISCOVERY
Monday 22 March
10-11 Master Inauguration
11-13 Alessandro Pini, Phage libraries in drug discovery
15-17 Chiara Falciani, Peptide libraries
Tuesday 23 March
10-12 Luisa Bracci, Targets and Markers in Drug Discovery
15-17 Luisa Bracci, Targets and Markers in Drug Discovery
Wednesday 24 March
10-12 Jean Denis Docquier, Antibiotics: Origin, Clinical applications,
15-17 Jean Denis Docquier, Discovery and Development of antibiotics
Thursday 25 March
10-12 Alessandro Pini, Development of recombinant antibodies and peptides
15-17 Chiara Falciani, Selection of hit leads from libraries, preclinical development of the best candidates.
April 2021 – PRECLINICAL DEVELOPMENT
Monday 19 April
10-12 Lucia Morbidelli, Toxicology -1
14-16 Sandra Donnini, New models of in vivo studies – 1
Tuesday 20 April
10-12 Lucia Morbidelli, Toxicology -2
14-17 Sandra Donnini, New models of in vivo studies – 2
Wednesday 21 April
9-12 Elsa Melloni, Non clinical development
14-17 Elsa Melloni, Principles of project management applied to pharmaceuticals R&D
Thursday 22 April
9-11 Stefano Manzini, Preclinical Development in Pharmaceutical Companies
11-13 Cristina Di Bugno, Chemical Development
14-16 Ronny Mueller, Pharmaceutical Drug Product Development
16-18 Monica Binaschi, Oncological Preclinical Development and Translational Medicine
May 2021 – PRECLINICAL AND CLINICAL DEVELOPMENT
Monday 17 May
9-12 Fabio Fusi, Specific examples of safety pharmacology
14-17 To be identified
Tuesday 18 May
9-12 Maurizio Zazzi, Basics of antiviral drug development and preclinical drug testing.
14-17 Maurizio Zazzi, Lessons from HIV: from the first anti-HIV drug to drug combinations
Wednesday 19 May
9-13 Jacopo Piazzi, Clinical Trials
15-17 Jacopo Piazzi, Recombinant antibodies in clinical trials
Thursday 20 May
10-13 Emanuele Montomoli, Public Private partnership in vaccines
June 2021 – CLINICAL TRIALS AND REGULATORY ISSUES
Monday 21 June
9-11 Rino Rappuoli, History of vaccines
11-13 Audino Podda, Clinical trials for vaccine development
15-18 Donata Medaglini, Profiling immune reponses in human vaccine clinical trials
Tuesday 22 June
10-12 Marco Pacini, Pharmacovigilance
14-16 Marco Pacini, International Legislation
Wednesday 23 June
9-11 Vanessa Ritrovato, Ethical Committees and Centres for Clinical Trials
11-13 Vanessa Ritrovato, Drug Approval and Pharmacovigilance
14-16 Elena Toschi, Management of multinational clinical trials in Europe: the ECRIN experience
Thursday 24 June
9-11 Alessandro Gringeri, Overview on Clinical Trials phase I-III
11-13 Alessandro Gringeri, Regulations and GCP
15-17 Alessandro Gringeri, Design of clinical trials: theory and practice
September 2021 – INTELLECTUAL PROPERTY AND DATA SCIENCE AND INTEGRATION
Monday 20 September
10-12 Paolo Banfi, Inventions and patents
14-16 Andrea Frosini, Patent filing and management
Tuesday 21 September
10-12 Simone Furini, Extracting information from data banks
14-16 Simone Furini, Practical examples related to drug development and clinical application
Wednesday 22 September.
10-12 Rosa Gini, Database and multi-database studies – 1
14-16 Rosa Gini, Database and multi-database studies – 2
Thursday, 23 September
10-12 Andrea Paolini, TLS
14-17 Gianni D’Errico, Big Data and clinical development
October 2021 – DATA SCIENCE AND INTEGRATION
Monday 18 October
10-12 Laura Salvini, Mass spectrometry applications in drug development -1
14-16 Laura Salvini, Mass spectrometry applications in drug development -2
Tuesday 19 October
10-12 Jlenia Brunetti, Cutting edge technologies for preclinical analysis and drug discovery – 1
14-16 Jlenia Brunetti, Cutting edge technologies for preclinical analysis and drug discovery – 2
Stages in companies or institutions involved in drug development will be organized in the following months.